SharesGrow.com 標普和納斯達克內在價值聯繫我們

हिन्दी

← 返回所有股票

Alnylam Pharmaceuticals, Inc. ALNY NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

SharesGrow Score

SharesGrow Intrinsic Value

Analyst Price Target

Alnylam Pharmaceuticals, Inc. (ALNY) 有 12 個已識別的同業可供比較在 Healthcare 板塊. 同業包括 AMLX, APLS, BMRN, BPMC, DAWN, EXEL 等.

ALNY 的市值為 $45.01B, 而同業平均市值為 $8.8B. ALNY 顯著大於其平均同業.

同行與相似公司 — ALNY

Amylyx Pharmaceuticals, Inc.

$16.92 +2.73% $1.41B

Apellis Pharmaceuticals, Inc.

$40.85 +0.02% $5.22B

BioMarin Pharmaceutical Inc.

$55.47 +1.08% $10.67B

Blueprint Medicines Corporation

$129.46 +0.14% $8.36B

Day One Biopharmaceuticals, Inc.

$21.46 -0.14% $2.22B

$45.86 +2.00% $12.3B

Halozyme Therapeutics, Inc.

$67.31 +0.49% $7.97B

Incyte Corporation

$97.69 +2.24% $19.44B

IVERIC bio, Inc.

$39.95 +0.38% $5.51B

Karuna Therapeutics, Inc.

$329.83 +0.03% $12.6B

Krystal Biotech, Inc.

$270.00 +0.97% $7.89B

Madrigal Pharmaceuticals, Inc.

$524.99 -0.13% $12.04B

其他人也在看

United Therapeutics Corporation

Incyte Corporation

Karuna Therapeutics, Inc.

Madrigal Pharmaceuticals, Inc.

BioMarin Pharmaceutical Inc.

Blueprint Medicines Corporation

聯繫我們

🎓

SharesGrow 學院

學習如何計算內在價值，發現被低估的股票。

每週線上課程

📧 [email protected]

📞 +65 8912 8000

給我們留言